Fanglin Yu

819 total citations
35 papers, 693 citations indexed

About

Fanglin Yu is a scholar working on Molecular Biology, Pharmaceutical Science and Biomaterials. According to data from OpenAlex, Fanglin Yu has authored 35 papers receiving a total of 693 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 7 papers in Pharmaceutical Science and 7 papers in Biomaterials. Recurrent topics in Fanglin Yu's work include Nanoparticle-Based Drug Delivery (7 papers), RNA Interference and Gene Delivery (6 papers) and Advanced Drug Delivery Systems (6 papers). Fanglin Yu is often cited by papers focused on Nanoparticle-Based Drug Delivery (7 papers), RNA Interference and Gene Delivery (6 papers) and Advanced Drug Delivery Systems (6 papers). Fanglin Yu collaborates with scholars based in China, Czechia and United States. Fanglin Yu's co-authors include Xingguo Mei, Zhiping Li, Wei Gong, Yang Yang, Xiangyang Xie, Zhiping Li, Ying Li, Xiangyang Xie, Zhiyuan Wang and Hui Zhang and has published in prestigious journals such as PLoS ONE, Biomaterials and Journal of Controlled Release.

In The Last Decade

Fanglin Yu

34 papers receiving 682 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fanglin Yu China 15 327 261 174 89 72 35 693
Caisheng Wu China 20 388 1.2× 182 0.7× 169 1.0× 47 0.5× 61 0.8× 54 987
Gigi N.C. Chiu Singapore 15 428 1.3× 275 1.1× 177 1.0× 79 0.9× 29 0.4× 19 916
Yifeng Pan China 14 327 1.0× 254 1.0× 151 0.9× 110 1.2× 25 0.3× 23 776
Yang Deng China 16 397 1.2× 219 0.8× 201 1.2× 79 0.9× 32 0.4× 28 889
Jiaxuan Xia China 15 620 1.9× 217 0.8× 209 1.2× 40 0.4× 39 0.5× 29 1.0k
Hitesh Kumar India 15 394 1.2× 291 1.1× 233 1.3× 165 1.9× 25 0.3× 33 975
Davoud Jafari-Gharabaghlou Iran 17 355 1.1× 204 0.8× 152 0.9× 79 0.9× 19 0.3× 42 871
Qiujun Qiu China 16 259 0.8× 158 0.6× 220 1.3× 65 0.7× 43 0.6× 19 727
Jilai Tian China 16 245 0.7× 155 0.6× 201 1.2× 94 1.1× 25 0.3× 32 720

Countries citing papers authored by Fanglin Yu

Since Specialization
Citations

This map shows the geographic impact of Fanglin Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fanglin Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fanglin Yu more than expected).

Fields of papers citing papers by Fanglin Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fanglin Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fanglin Yu. The network helps show where Fanglin Yu may publish in the future.

Co-authorship network of co-authors of Fanglin Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Fanglin Yu. A scholar is included among the top collaborators of Fanglin Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fanglin Yu. Fanglin Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Gao, Yue, Siyu Ma, Yumei Zhao, et al.. (2021). A novel preparative method for nanoparticle albumin-bound paclitaxel with high drug loading and its evaluation both in vitro and in vivo. PLoS ONE. 16(4). e0250670–e0250670. 33 indexed citations
4.
Yang, Hui-Min, et al.. (2021). EGFR mutation status in non-small cell lung cancer receiving PD-1/PD-L1 inhibitors and its correlation with PD-L1 expression: a meta-analysis. Cancer Immunology Immunotherapy. 71(5). 1001–1016. 17 indexed citations
5.
Yang, Shimin, Fanglin Yu, Mingyan Lin, et al.. (2020). Single-nucleotide polymorphism rs17548629 in RIPK1 gene may be associated with lung cancer in a young and middle-aged Han Chinese population. Cancer Cell International. 20(1). 143–143. 7 indexed citations
6.
Liang, Xi, Yabing Hua, Qian Liu, et al.. (2020). Solid Self-Emulsifying Drug Delivery System (Solid SEDDS) for Testosterone Undecanoate: In Vitro and In Vivo Evaluation. Current Drug Delivery. 18(5). 620–633. 1 indexed citations
7.
Gao, Yue, Xuemei Tang, Wei Lei, et al.. (2019). Development and Evaluation of Ropivacaine Loaded Poly(Lactic-Co-Glycolic Acid) Microspheres with Low Burst Release. Current Drug Delivery. 16(6). 490–499. 10 indexed citations
8.
Li, Lin, Xiaoqin Hu, Min Zhang, et al.. (2017). Dual Tumor-Targeting Nanocarrier System for siRNA Delivery Based on pRNA and Modified Chitosan. Molecular Therapy — Nucleic Acids. 8. 169–183. 25 indexed citations
9.
Hu, Xiaoqin, Jianwei Zhang, Xuemei Tang, et al.. (2017). An Accelerated Release Method of Risperidone Loaded PLGA Microspheres with Good IVIVC. Current Drug Delivery. 15(1). 87–96. 21 indexed citations
10.
Chen, Meiling, Ying Li, Fanglin Yu, et al.. (2017). Simultaneous determination of metolazone and valsartan in plasma by on-line SPE coupled with liquid chromatography/tandem mass spectrometry. European Journal of Mass Spectrometry. 23(5). 305–312. 4 indexed citations
11.
Ma, Siyu, Mingyuan Li, Nan Liu, et al.. (2017). Vincristine liposomes with smaller particle size have stronger diffusion ability in tumor and improve tumor accumulation of vincristine significantly. Oncotarget. 8(50). 87276–87291. 10 indexed citations
12.
Yang, Yang, Mingyuan Li, Zhiping Li, et al.. (2017). Dual-stimuli responsive nanoparticle system for enhanced and targeted cancer therapy. Journal of Controlled Release. 259. e166–e167. 2 indexed citations
13.
Chen, Meiling, Le Mei, Fanglin Yu, et al.. (2017). Simultaneous Determination of Felodipine and Metoprolol in Beagle Dog Plasma by Online SPE-LC-MS/MS and Its Application in a Pharmacokinetic Study. Analytical Sciences. 33(7). 755–759. 9 indexed citations
14.
Li, Haotian, Shiyong Fan, Zhiping Li, et al.. (2016). Synthesis and evaluation of novel α-aminoamides with substituted benzene scaffold for the treatment of neuropathic pain. Chinese Chemical Letters. 27(10). 1630–1634. 3 indexed citations
15.
Zhao, Shiqing, Fanglin Yu, Nan Liu, et al.. (2016). Synchronous delivery of felodipine and metoprolol tartrate using monolithic osmotic pump technology. Drug Development and Industrial Pharmacy. 42(11). 1723–1731. 8 indexed citations
16.
Xie, Xiangyang, et al.. (2015). Preparation, characterization and pulmonary pharmacokinetics of a new inhalable zanamivir dry powder. Drug Delivery. 23(6). 1–10. 23 indexed citations
17.
Yang, Yang, Yanfang Yang, Xiangyang Xie, et al.. (2015). Dual-modified liposomes with a two-photon-sensitive cell penetrating peptide and NGR ligand for siRNA targeting delivery. Biomaterials. 48. 84–96. 85 indexed citations
18.
Gong, Wei, Zhiyuan Wang, Bingsheng Li, et al.. (2015). A novel drug-polyethylene glycol liquid compound method to prepare 10-hydroxycamptothecin loaded human serum albumin nanoparticle. International Journal of Pharmaceutics. 490(1-2). 412–428. 22 indexed citations
20.
Ma, Guannan, Fanglin Yu, Shan Wang, et al.. (2014). A Novel Oral Preparation of Hydroxysafflor Yellow A Base on a Chitosan Complex: A Strategy to Enhance the Oral Bioavailability. AAPS PharmSciTech. 16(3). 675–682. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026